Quarterly report · Q1
2590.TEDINET S100TJG2
Period2024-01-21 → 2024-04-20
Filed2024-06-03
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥53.2bn | 2024-01-21 → 2024-04-20 | Cons. | Net sales |
| Revenue | ¥213.4bn | 2023-01-21 → 2024-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥47.1bn | 2023-01-21 → 2023-04-20 | Cons. | Net sales |
| Operating income | −¥611m | 2024-01-21 → 2024-04-20 | Cons. | Operating income |
| Operating income | −¥539m | 2023-01-21 → 2023-04-20 | Cons. | Operating income |
| Ordinary income | −¥1.3bn | 2024-01-21 → 2024-04-20 | Cons. | Ordinary income |
| Ordinary income | ¥3.1bn | 2023-01-21 → 2024-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥442m | 2023-01-21 → 2023-04-20 | Cons. | Ordinary income |
| Profit before tax | ¥3.8bn | 2024-01-21 → 2024-04-20 | Cons. | Income before income taxes |
| Profit before tax | −¥87m | 2023-01-21 → 2023-04-20 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.1bn | 2024-01-21 → 2024-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.4bn | 2023-01-21 → 2024-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥296m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.9bn | 2024-01-21 → 2024-04-20 | Cons. | Profit loss |
| Net income | −¥299m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss |
| Total assets | ¥189.3bn | at 2024-04-20 | Cons. | Assets |
| Total assets | ¥177.6bn | at 2024-01-20 | Cons. | Assets |
| Total assets | ¥179.1bn | at 2023-04-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥98.7bn | at 2024-04-20 | Cons. | Liabilities |
| Total liabilities | ¥86.1bn | at 2024-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥90.6bn | at 2024-04-20 | Cons. | Net assets |
| Net assets / equity | ¥91.5bn | at 2024-01-20 | Cons. | Net assets |
| Net assets / equity | ¥88.5bn | at 2023-04-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥36.7bn | at 2024-04-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥32.4bn | at 2024-01-20 | Cons. | Cash and deposits |
| EPS (basic) | ¥99.91 | 2024-01-21 → 2024-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥140.77 | 2023-01-21 → 2024-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-9.45 | 2023-01-21 → 2023-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 47.0% | at 2024-04-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2024-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.4% | at 2023-04-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-21 → 2024-04-20 | −¥90m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-21 → 2024-04-20 | −¥90m |
| Reconciling Itemsreconciling | segment profit | 2024-01-21 → 2024-04-20 | −¥270m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2024-01-21 → 2024-04-20 | ¥33.9bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2024-01-21 → 2024-04-20 | ¥33.9bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2024-01-21 → 2024-04-20 | ¥3m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2024-01-21 → 2024-04-20 | −¥1.3bn |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2024-01-21 → 2024-04-20 | −¥154m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2024-01-21 → 2024-04-20 | ¥4.4bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2024-01-21 → 2024-04-20 | ¥4.4bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2024-01-21 → 2024-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2024-01-21 → 2024-04-20 | ¥227m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2024-01-21 → 2024-04-20 | ¥11.5bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2024-01-21 → 2024-04-20 | ¥11.5bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2024-01-21 → 2024-04-20 | ¥709m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2024-01-21 → 2024-04-20 | ¥3.5bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2024-01-21 → 2024-04-20 | ¥3.4bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2024-01-21 → 2024-04-20 | ¥85m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2024-01-21 → 2024-04-20 | ¥170m |
| —segment total | revenue | 2024-01-21 → 2024-04-20 | ¥53.3bn |
| —segment total | revenue external | 2024-01-21 → 2024-04-20 | ¥53.2bn |
| —segment total | revenue intersegment | 2024-01-21 → 2024-04-20 | ¥90m |
| —segment total | segment profit | 2024-01-21 → 2024-04-20 | −¥340m |
| Reconciling Itemsreconciling | revenue | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | segment profit | 2023-01-21 → 2023-04-20 | −¥151m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥238m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥133m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥84m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥63m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| —segment total | revenue | 2023-01-21 → 2023-04-20 | ¥47.2bn |
| —segment total | revenue external | 2023-01-21 → 2023-04-20 | ¥47.1bn |
| —segment total | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥77m |
| —segment total | segment profit | 2023-01-21 → 2023-04-20 | −¥387m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 390
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 5286000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 3035000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 4128000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 47179000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -77000000 | JPY |
| Net sales | Prior1YTDDuration | 47102000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | -238000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | -84000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 34000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 34000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | -133000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | -387000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -151000000 | JPY |
| Operating income | Prior1YTDDuration | -539000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 33934000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 11460000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 3386000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 4382000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 53164000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 53164000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 3000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 85000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 90000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -90000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 33937000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 11460000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 3472000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 4384000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 53255000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -90000000 | JPY |
| Net sales | CurrentYTDDuration | 53164000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | -1293000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 709000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 170000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 227000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | -154000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | -340000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -270000000 | JPY |
| Operating income | CurrentYTDDuration | -611000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |